Literature DB >> 20824891

Hemangioma in the newborn: increased incidence after chorionic villus sampling.

Constantijn G Bauland1, Jeroen M Smit, Lidewij R Bartelink, Hans A Zondervan, Paul H M Spauwen.   

Abstract

OBJECTIVES: This study was designed to compare the effects of transcervical chorionic villus sampling (CVS) and amniocentesis on the prevalence of hemangiomas of infancy.
METHODS: This is a cohort study of 250 consecutive assessable transabdominal amniocentesis procedures and 250 consecutive assessable transcervical CVS procedures performed between January and September 2002. Parents were asked to fill out a questionnaire regarding the presence of any type of skin lesions. Based on the responses to the questionnaire, children were invited to undergo a physical examination to confirm hemangiomas.
RESULTS: Questionnaires were returned in 78% of the CVS group (195/250) and in 72% of the amniocentesis group (180/250). Based on the responses in the questionnaire, 78 children in the CVS group and 42 in the amniocentesis group underwent a physical examination. One or more hemangiomas were present in 53 of 195 (27.2%) children in the CVS group versus 17 of 180 (9.4%) children in the amniocentesis group (odds ratio 3.6, 95% CI: 2.0-6.5). There was no difference in congenital abnormalities between the two groups.
CONCLUSION: Transcervical CVS is associated with a significantly increased prevalence of hemangiomas compared with amniocentesis. The clinical features of these hemangiomas do not differ from natural hemangiomas and complications of these hemangiomas are very rare.
© 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20824891     DOI: 10.1002/pd.2562

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  12 in total

1.  What is your diagnosis?

Authors:  Cihan Cetin; Selim Büyükkurt; Serdar Aykut; Cansun Demir
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-06-01

2.  Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma.

Authors:  Maria I New; Yu K Tong; Tony Yuen; Peiyong Jiang; Christian Pina; K C Allen Chan; Ahmed Khattab; Gary J W Liao; Mabel Yau; Se-Min Kim; Rossa W K Chiu; Li Sun; Mone Zaidi; Y M Dennis Lo
Journal:  J Clin Endocrinol Metab       Date:  2014-02-28       Impact factor: 5.958

3.  Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis.

Authors:  Xiaowen Liu; Renrong Lv; Linfeng Zhang; Guangqi Xu; Jianhai Bi; Feng Gao; Jian Zhang; Feng Xue; Fagang Wang; Yiliang Wu; Cong Fu; Qiang Wang; Ran Huo
Journal:  Tumour Biol       Date:  2016-10-05

4.  The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment.

Authors:  James R Dornhoffer; Ting Wei; Haihong Zhang; Emily Miller; Mario A Cleves; Gresham T Richter
Journal:  Pediatr Res       Date:  2017-05-03       Impact factor: 3.756

Review 5.  Update on Treatment of Infantile Hemangiomas: What's New in the Last Five Years?

Authors:  Laura Macca; Domenica Altavilla; Luca Di Bartolomeo; Natasha Irrera; Francesco Borgia; Federica Li Pomi; Federico Vaccaro; Violetta Squadrito; Francesco Squadrito; Mario Vaccaro
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

6.  Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.

Authors:  Graham M Strub; Andrew L Kirsh; Mark E Whipple; Winston P Kuo; Rachel B Keller; Raj P Kapur; Mark W Majesky; Jonathan A Perkins
Journal:  JCI Insight       Date:  2016-09-08

Review 7.  Complex vascular anomalies.

Authors:  Richard G Azizkhan
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

8.  Risk of infantile hemangiomas in the offspring of women with autoimmune disease and the pathogenic implications of these lesions.

Authors:  Chelsey J F Smith; Kenneth L Jones; Diana L Johnson; Gretchen Bandoli; Loan K Robinson; Arthur Kavanaugh; Christina D Chambers
Journal:  Am J Med Genet A       Date:  2018-01-17       Impact factor: 2.802

Review 9.  Biology of infantile hemangioma.

Authors:  Tinte Itinteang; Aaron H J Withers; Paul F Davis; Swee T Tan
Journal:  Front Surg       Date:  2014-09-25

10.  Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro.

Authors:  Yalin Zhu; Aerziguli Tuerxun; Yan Hui; Paride Abliz
Journal:  Exp Ther Med       Date:  2014-06-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.